Sonali M Smith

Sonali M Smith

UNVERIFIED PROFILE

Are you Sonali M Smith?   Register this Author

Register author
Sonali M Smith

Sonali M Smith

Publications by authors named "Sonali M Smith"

Are you Sonali M Smith?   Register this Author

100Publications

3032Reads

42Profile Views

Work-Life Balance Solutions for Physicians-It's All About You, Your Work, and Others.

Mayo Clin Proc 2019 Apr;94(4):573-576

Section of Hematology/Oncology, The University of Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2018.11.021DOI Listing
April 2019

Double hit and double expressors in lymphoma: Definition and treatment.

Cancer 2018 Dec 25;124(24):4622-4632. Epub 2018 Sep 25.

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31646DOI Listing
December 2018

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.

N Engl J Med 2018 Nov;379(18):1711-1721

From Stanford University, Stanford (R.A., T.T., R.M., I.L.W.), City of Hope, Duarte (L.P.), and Forty Seven, Menlo Park (J.L., J.Y.C., J.-P.V., B.A., J.H., R.M., I.L.W., C.H.T., M.P.C.) - all in California; Sarah Cannon Research Institute-Tennessee Oncology, Nashville (I.F.); University of Alabama at Birmingham, Birmingham (A.F.); Washington University in St. Louis, St. Louis (N.L.B.); Levine Cancer Institute-Atrium Health, Charlotte, NC (N.G.); University of Chicago, Chicago (J.K., S.M.S.); National Cancer Institute, Rockville, MD (M.R.); Dana-Farber Cancer Institute, Boston (A.L.); and University of Oxford, Oxford, United Kingdom (G.P.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1807315DOI Listing
November 2018

Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma.

J Clin Oncol 2018 Oct 4;36(30):3015-3022. Epub 2018 Sep 4.

Andrew M. Evens, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Ranjana H. Advani, Stanford University, Stanford, CA; Irene B. Helenowski, Borko D. Jovanovic, Jane N. Winter, and Leo I. Gordon, Northwestern University Feinberg School of Medicine; Jane N. Winter and Leo I. Gordon, Robert H. Lurie Comprehensive Cancer Center; Sonali M. Smith, University of Chicago, Chicago, IL; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Gregory R. Bociek, University of Nebraska, Omaha, NE; Andreas K. Klein, Tufts Medical Center, Boston, MA; and Paul A. Hamlin, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.0139DOI Listing
October 2018

An update in treating transformed lymphoma.

Best Pract Res Clin Haematol 2018 09 25;31(3):251-261. Epub 2018 Jul 25.

Section of Hematology/Oncology, Department of Medicine, The University of Chicago, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2018.07.008DOI Listing
September 2018

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016.

J Clin Oncol 2018 03 22;36(7):697-703. Epub 2018 Jan 22.

Mazyar Shadman, Ajay K. Gopal, David G. Maloney, and Oliver W. Press, University of Washington and Fred Hutchinson Cancer Research Center; Hongli Li and Michael LeBlanc, SWOG Statistical Center, Seattle, WA; Lisa Rimsza, Mayo Clinic Arizona, Scottsdale; Catherine M. Spier, University of Arizona, Tucson, AZ; John P. Leonard, Weill Cornell Medical College, New York; Jonathan W. Friedberg, Wilmot Cancer Institute, University of Rochester, Rochester, NY; Mark S. Kaminski, University of Michigan Health System, Ann Arbor, MI; Rita M. Braziel, Oregon Health & Science University, Portland, OR; Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC; Shaker Dakhil, University of Kansas School of Medicine-Wichita, Wichita, KS; Sonali M. Smith, University of Chicago Medicine, Chicago, IL; and Richard I. Fisher, Fox Chase Cancer Center and Temple University School of Medicine, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.5083
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.5083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553811PMC
March 2018

Should We Use Cell of Origin and Dual-protein Expression in Treating DLBCL?

Clin Lymphoma Myeloma Leuk 2018 02 24;18(2):91-97. Epub 2017 Dec 24.

Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.12.003DOI Listing
February 2018

Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma.

Biol Blood Marrow Transplant 2018 01 13;24(1):78-85. Epub 2017 Oct 13.

Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.10.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743624PMC
January 2018

Understanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice.

Am Soc Clin Oncol Educ Book 2017 ;37:535-546

From the Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Wilmot Cancer Institute, University of Rochester, Rochester, NY; Section of Hematology/Oncology, The University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324533PMC
December 2017

Extranodal Marginal Zone Lymphoma: No Longer Just a Sidekick.

J Clin Oncol 2017 Jun 27;35(17):1872-1878. Epub 2017 Apr 27.

Manali K. Kamdar and Sonali M. Smith, The University of Colorado, Denver, CO; and The University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2835DOI Listing
June 2017

Treatment of aggressive B-cell lymphomas.

Authors:
Sonali M Smith

Hematol Oncol 2017 Jun;35 Suppl 1:84-87

The University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2407DOI Listing
June 2017

Ofatumumab monotherapy in relapsed/refractory diffuse large B-cell non-Hodgkin lymphoma.

Leuk Lymphoma 2017 03 14;58(3):752-753. Epub 2016 Jul 14.

a The University of Chicago Medical Center , Chicago , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1207764DOI Listing
March 2017

Impact of Double-Hit and Double-Expressor Phenotypes in Relapsed Aggressive B-Cell Lymphomas Treated With Autologous Hematopoietic Stem Cell Transplantation.

Authors:
Sonali M Smith

J Clin Oncol 2017 01 24;35(1):1-3. Epub 2016 Oct 24.

Sonali M. Smith, The University of Chicago, Chicago IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.0625DOI Listing
January 2017

Aggressive B-cell lymphoma: the double-hit and double-expressor phenotypes.

Authors:
Sonali M Smith

Clin Adv Hematol Oncol 2017 Jan;15(1):40-42

The University of Chicago Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
January 2017

ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II.

Am J Clin Oncol 2016 12;39(6):535-544

*University of Rochester Medical Center, Rochester †††Memorial Sloan Kettering Cancer Center, American Society of Clinical Oncology, New York, NY †Stanford Cancer Center, American Society of Clinical Oncology, Stanford ‡University of Southern California Keck School of Medicine, Los Angeles, CA §University of Texas MD Anderson Cancer Center, Houston ¶University of Texas Health Science Center at San Antonio, San Antonio, TX ∥Emory University, American Society of Clinical Oncology, Atlanta, GA #University of Florida Proton Therapy Institute, Jacksonville **University of Florida, Gainesville, FL ††St. Jude Children's Research Hospital, American Society of Clinical Oncology, Memphis, TN ‡‡University of Pennsylvania Health System, Philadelphia, PA §§Yale University School of Medicine, New Haven, CT ∥∥Richard L. Roudebush VA Medical Center, Indiana University School of Medicine, Indianapolis, IN ¶¶The University of Chicago, American Society of Hematology, Chicago, IL ##Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, MD ***Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000331DOI Listing
December 2016

Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.

J Natl Cancer Inst 2016 12 16;108(12). Epub 2016 Dec 16.

Department of Medicine, Mayo Clinic, Rochester, MN (GSN); Department of Internal Medicine, Ohio State University, Columbus, OH (KAB); Department of Medicine, Oncology Division, Washington University, St. Louis, MO (BSK); Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester, Rochester, NY (JWF); Coordinating Center for Clinical Trials (LB), Division of Cancer Treatment and Diagnosis (RFL), and Center for Cancer Research (WHW), National Cancer Institute, National Institute of Health, Bethesda, MD; Division of Oncology, University of Washington, Seattle WA (DGM); British Colombia Cancer Agency, Vancouver, BC (LHS); Department of Medicine, University of Virginia, Charlottesville, VA (MEW); Department of Medicine, Weil Cornell University, New York, NY (JPL); Department of Medicine, University of Chicago, Chicago, IL (SMS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080361PMC
December 2016

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

J Clin Oncol 2016 09 6;34(26):3141-9. Epub 2016 Jun 6.

Nilanjan Ghosh, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC; Reem Karmali, Rush University Medical Center; Sonali M. Smith, The University of Chicago, Chicago, IL; Vanderson Rocha, Churchill Hospital, Oxford, United Kingdom; Kwang Woo Ahn, Alyssa DiGilio, and Mehdi Hamadani, Medical College of Wisconsin & Center for International Blood and Marrow Transplant Research; Parameswaran N. Hari and Anita D'Souza, Medical College of Wisconsin; Timothy S. Fenske, Froedtert Memorial Lutheran Hospital, Milwaukee, WI; Veronika Bachanova, University of Minnesota Medical Center, Minneapolis, MN; Ulrike Bacher, University Medicine Goettingen and University Cancer Center Hamburg, Hamburg, Germany; Parastoo Dahi, Memorial Sloan Kettering Cancer Center-Adults, New York, NY; Marcos de Lima, University Hospitals Case Medical Center, Cleveland; Samantha Jaglowski, The Ohio State University Medical Center, Columbus, OH; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Tim D. Prestidge, Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand; Bipin N. Savani, Vanderbilt University Medical Center, Nashville, TN; Anna M. Sureda, European Group for Blood and Marrow Transplantation and Hospital Duran I Reynals, Barcelona, Spain; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Alex F. Herrera, City of Hope National Medical Center, Duarte, CA; Philippe Armand, Dana-Farber Cancer Institute, Boston, MA; Rachel B. Salit, Fred Hutchinson Cancer Research Center, Seattle, WA; and Nina D. Wagner-Johnston, Ephraim Fuchs, and Javier Bolaños-Meade, Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012706PMC
September 2016

Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736.

J Clin Oncol 2016 09 5;34(25):2997-3004. Epub 2016 Jul 5.

Deborah M. Stephens, University of Utah, Salt Lake City, UT; Hongli Li and Michael L. LeBlanc, Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; Soham D. Puvvada and Daniel Persky, University of Arizona, Tucson, AZ; Jonathan W. Friedberg, Wilmot Cancer Institute, University of Rochester, Rochester, NY; and Sonali M. Smith, University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.4582DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012710PMC
September 2016

ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.

Am J Clin Oncol 2016 08;39(4):384-95

*Yale University School of Medicine, New Haven, CT †Memorial Sloan Kettering Cancer Center, New York, American Society of Clinical Oncology ¶University of Rochester Medical Center, Rochester, NY ‡Princess Margaret Hospital, Toronto, ON, Canada §Stanford Cancer Center, Stanford, CA, American Society of Clinical Oncology ∥University of Texas MD Anderson Cancer Center, Houston **University of Texas Health Science Center at San Antonio, San Antonio, TX #Emory University, Atlanta, GA, American Society of Clinical Oncology ††University of Florida Proton Therapy Institute, Jacksonville ‡‡University of Florida, Gainesville, FL §§St Jude Children's Research Hospital, Memphis, TN, American Society of Clinical Oncology ∥∥University of Pennsylvania Health System, Philadelphia, PA ¶¶Richard L. Roudebush VA Medical Center, Indiana University School of Medicine, Indianapolis, IN ##The University of Chicago, Chicago, IL, American Society of Hematology ***Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, MD †††Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000294DOI Listing
August 2016

Surveillance Imaging in Patients in Remission From Hodgkin and Diffuse Large B-Cell Lymphoma.

JAMA 2016 May;315(19):2115-6

Section of General Internal Medicine, University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2016.4913DOI Listing
May 2016

Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib.

Oncotarget 2016 Jan;7(4):4598-610

Division of Genomic and Molecular Pathology, Department of Pathology, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.6727DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826229PMC
January 2016

ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma.

Am J Clin Oncol 2015 Dec;38(6):610-20

*University of Texas MD Anderson Cancer Center, Houston, TX †American Society of Clinical Oncology, Stanford Cancer Center, Stanford, CA ‡Princess Margaret Hospital, Toronto, Ontario, Canada §University of Rochester Medical Center ‡‡‡University of Rochester Medical Center, Rochester †††American Society of Clinical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY ∥American Society of Clinical Oncology, Emory University, Atlanta, GA ¶Univeristy of Texas Health Science Center at San Antonio, San Antonio, TX #University of Florida Proton Therapy Institute, Jacksonville **University of Florida, Gainesville, FL ††American Society of Clinical Oncology, St. Jude Children's Research Hospital, Memphis, TN ‡‡University of Pennsylvania Health System, Philadelphia, PA §§Yale University School of Medicine, New Haven, CT ∥∥Richard L. Roudebush VA Medical Center, Indiana University School of Medicine, Indianapolis, IN ¶¶American Society of Hematology, University of Chicago, Chicago, IL ##Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, MD ***Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/COC.0000000000000215DOI Listing
December 2015

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma.

N Engl J Med 2015 Nov;373(19):1835-44

From the Meyer Cancer Center, Division of Hematology and Medical Oncology (J.R., P.M., R.R.F., A.R., J.L., O.K., M.C., J.P.L.), and Division of Biostatistics and Epidemiology (P.C.), Weill Cornell Medical College and New York-Presbyterian Hospital, New York; Moffitt Cancer Center, Tampa, FL (B.S.); University of Pennsylvania Abramson Cancer Center, Philadelphia (S.J.S., J.S.); and the University of Chicago Medical Center, Chicago (S.M.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1505237DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710541PMC
November 2015

Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non-Hodgkin lymphoma.

Br J Haematol 2015 Aug 9;170(4):445-56. Epub 2015 Apr 9.

Division of Genomic and Molecular Pathology, Department of Pathology, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13427DOI Listing
August 2015

Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.

J Clin Oncol 2015 Jul 15;33(21):2399-404. Epub 2015 Jun 15.

Paul M. Barr and Jonathan W. Friedberg, University of Rochester, Rochester; Steven M. Horwitz, Memorial Sloan Kettering Cancer Center, New York, NY; Hongli Li and Michael LeBlanc, SWOG Statistical Office, Seattle, WA; Catherine Spier, University of Arizona College of Medicine, Tucson, AZ; Daruka Mahadevan, Mansoor Ul Haq, and Bryan D. Huber, University of Tennessee Health Sciences Center, Memphis, TN; Christopher R. Flowers, Emory University, Atlanta, GA; Nina D. Wagner-Johnston and Nancy L. Bartlett, Washington University School of Medicine, St. Louis, MO; Richard I. Fisher, Temple University, Philadelphia, PA; Bruce D. Cheson, Georgetown University Hospital, Washington, DC; Sonali M. Smith, The University of Chicago, Chicago, IL; and Brad S. Kahl, University of Wisconsin, Madison, WI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.6327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500834PMC
July 2015

Hematopoietic stem cell transplantation in nodal T cell non-hodgkin lymphomas: revisiting the issues.

Biol Blood Marrow Transplant 2015 May 14;21(5):777-9. Epub 2015 Mar 14.

Department of Medicine, The University of Chicago, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.03.009DOI Listing
May 2015

New drugs for the treatment of non-Hodgkin lymphomas.

Authors:
Sonali M Smith

Chin Clin Oncol 2015 Mar;4(1):14

Section of Hematology/Oncology, Lymphoma Program, The University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2015.03.01DOI Listing
March 2015

MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.

Cancer 2014 Dec 24;120(24):3884-95. Epub 2014 Jul 24.

Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28899DOI Listing
December 2014

Phosphoinositide 3-kinase inhibitors in lymphoma.

Curr Opin Oncol 2014 Sep;26(5):469-75

Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441952PMC
September 2014

Dietary patterns and the risk of non-Hodgkin lymphoma.

Public Health Nutr 2014 Jul 9;17(7):1531-7. Epub 2013 May 9.

2Department of Health Studies,University of Chicago,5841 South Maryland Avenue,MC 2007,Chicago,IL 60637,USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1368980013001249DOI Listing
July 2014

Dissecting follicular lymphoma: high versus low risk.

Authors:
Sonali M Smith

Hematology Am Soc Hematol Educ Program 2013 ;2013:561-7

1Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2013.1.561DOI Listing
July 2014

The impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatment eras.

Am J Hematol 2014 Jun 10;89(6):633-8. Epub 2014 Apr 10.

Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23708DOI Listing
June 2014

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.

J Clin Oncol 2014 Feb 16;32(4):273-81. Epub 2013 Dec 16.

Timothy S. Fenske and Mehdi Hamadani, Medical College of Wisconsin; Mei-Jie Zhang, Jeanette Carreras, and Parameswaran N. Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; Ernesto Ayala, H. Lee Moffitt Cancer Center and Research Institute, Tampa; Baldeep M. Wirk, Shands Healthcare and University of Florida, Gainesville, FL; Linda J. Burns, University of Minnesota Medical Center, Fairview, Minneapolis; David J. Inwards, Mayo Clinic Rochester, Rochester, MN; Amanda Cashen, Barnes Jewish Hospital, Washington University School of Medicine, St. Louis, MO; Luciano J. Costa, Medical University of South Carolina, Charleston, SC; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center, San Antonio, TX; Robert P. Gale, Imperial College; Silvia Montoto, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; Leona A. Holmberg and David G. Maloney, Fred Hutchinson Cancer Research Center, Seattle, WA; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Reinhold Munker, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA; Miguel-Angel Perales, Memorial Sloan-Kettering Cancer Center, New York, NY; David A. Rizzieri, Duke University Medical Center, Durham, NC; Harry C. Schouten, Academische Ziekenhuis Maastricht, Maastricht, the Netherlands; Sonali M. Smith, University of Chicago Hospitals, Chicago, IL; Edmund K. Waller, Emory University Hospital, Atlanta, GA; and Ginna G. Laport, Stanford Hospital and Clinics, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.2454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897255PMC
February 2014

Honing in on the (epi)genetic basis of AITL.

Authors:
Sonali M Smith

Blood 2014 Feb;123(9):1285-6

THE UNIVERSITY OF CHICAGO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-01-547265DOI Listing
February 2014

Dietary intake of fruits and vegetables and overall survival in non-Hodgkin lymphoma.

Leuk Lymphoma 2013 Dec 30;54(12):2613-9. Epub 2013 Apr 30.

Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center , Cincinnati, OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.784968DOI Listing
December 2013

Pre-diagnosis cigarette smoking and overall survival in non-Hodgkin lymphoma.

Br J Haematol 2013 Nov 2;163(3):352-6. Epub 2013 Aug 2.

Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Health Studies, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.12512
Publisher Site
http://dx.doi.org/10.1111/bjh.12512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797194PMC
November 2013

A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas.

Br J Haematol 2013 Oct 8;163(1):55-61. Epub 2013 Aug 8.

Division of Hematology/Oncology, Tufts University School of Medicine, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12488DOI Listing
October 2013

An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA.

Leuk Lymphoma 2013 Aug 7;54(8):1677-83. Epub 2013 Feb 7.

Department of Health Studies, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.760041DOI Listing
August 2013

Dietary nitrate and nitrite intake and risk of non-Hodgkin lymphoma.

Leuk Lymphoma 2013 May 24;54(5):945-50. Epub 2012 Oct 24.

Department of Health Studies, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.734613DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454474PMC
May 2013

Toward a global understanding of lymphoma: epidemiologic clues from the second most populous country.

Leuk Lymphoma 2013 May 10;54(5):901-2. Epub 2013 Jan 10.

Department of Health Studies, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.760042DOI Listing
May 2013

A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas.

Cancer 2013 May 10;119(9):1683-9. Epub 2013 Jan 10.

Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.27917
Publisher Site
http://dx.doi.org/10.1002/cncr.27917DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332882PMC
May 2013

Rapid neurologic decline in a patient with peripheral T-cell lymphoma: a case of leptomeningeal lymphomatosis.

Clin Lymphoma Myeloma Leuk 2013 Feb 18;13(1):70-2. Epub 2012 Sep 18.

Department of Neurology, Cedars-Sinai Medical Center, West Hollywood, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2012.07.002DOI Listing
February 2013

Marginal zone lymphoma of the thoracic dura causing spinal cord compression.

J Clin Neurosci 2013 Jan 16;20(1):171-3. Epub 2012 Sep 16.

Section of Neurosurgery, Department of Surgery, University of Chicago Medical Center, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2012.01.042DOI Listing
January 2013

Phytanic acid and the risk of non-Hodgkin lymphoma.

Carcinogenesis 2013 Jan 5;34(1):170-5. Epub 2012 Oct 5.

Department of Health Studies, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgs315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534193PMC
January 2013